194 related articles for article (PubMed ID: 28993312)
1. MMP-14 overexpression correlates with the neurodegenerative process in familial amyloidotic polyneuropathy.
Martins D; Moreira J; Gonçalves NP; Saraiva MJ
Dis Model Mech; 2017 Oct; 10(10):1253-1260. PubMed ID: 28993312
[TBL] [Abstract][Full Text] [Related]
2. Protective role of anakinra against transthyretin-mediated axonal loss and cell death in a mouse model of familial amyloidotic polyneuropathy.
Gonçalves NP; Teixeira-Coelho M; Saraiva MJ
J Neuropathol Exp Neurol; 2015 Mar; 74(3):203-17. PubMed ID: 25668561
[TBL] [Abstract][Full Text] [Related]
3. The inflammatory response to sciatic nerve injury in a familial amyloidotic polyneuropathy mouse model.
Gonçalves NP; Teixeira-Coelho M; Saraiva MJ
Exp Neurol; 2014 Jul; 257():76-87. PubMed ID: 24800914
[TBL] [Abstract][Full Text] [Related]
4. Schwann cells contribute to neurodegeneration in transthyretin amyloidosis.
Murakami T; Sango K; Watabe K; Niimi N; Takaku S; Li Z; Yamamura K; Sunada Y
J Neurochem; 2015 Jul; 134(1):66-74. PubMed ID: 25693163
[TBL] [Abstract][Full Text] [Related]
5. Tissue remodeling after interference RNA mediated knockdown of transthyretin in a familial amyloidotic polyneuropathy mouse model.
Gonçalves NP; Gonçalves P; Magalhães J; Ventosa M; Coelho AV; Saraiva MJ
Neurobiol Aging; 2016 Nov; 47():91-101. PubMed ID: 27568093
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-1 signaling pathway as a therapeutic target in transthyretin amyloidosis.
Gonçalves NP; Vieira P; Saraiva MJ
Amyloid; 2014 Sep; 21(3):175-84. PubMed ID: 24918964
[TBL] [Abstract][Full Text] [Related]
7. Neurodegeneration in familial amyloid polyneuropathy: from pathology to molecular signaling.
Sousa MM; Saraiva MJ
Prog Neurobiol; 2003 Dec; 71(5):385-400. PubMed ID: 14757117
[TBL] [Abstract][Full Text] [Related]
8. Activation of ERK1/2 MAP kinases in familial amyloidotic polyneuropathy.
Monteiro FA; Sousa MM; Cardoso I; do Amaral JB; Guimarães A; Saraiva MJ
J Neurochem; 2006 Apr; 97(1):151-61. PubMed ID: 16515552
[TBL] [Abstract][Full Text] [Related]
9. Gene therapy approach to FAP: in vivo influence of T119M in TTR deposition in a transgenic V30M mouse model.
Batista AR; Gianni D; Ventosa M; Coelho AV; Almeida MR; Sena-Esteves M; Saraiva MJ
Gene Ther; 2014 Dec; 21(12):1041-50. PubMed ID: 25273354
[TBL] [Abstract][Full Text] [Related]
10. The Expression of Chemokines Is Downregulated in a Pre-Clinical Model of TTR V30M Amyloidosis.
Moreira J; Costelha S; Saraiva M; Saraiva MJ
Front Immunol; 2021; 12():650269. PubMed ID: 34093538
[TBL] [Abstract][Full Text] [Related]
11. Deposition of transthyretin in early stages of familial amyloidotic polyneuropathy: evidence for toxicity of nonfibrillar aggregates.
Sousa MM; Cardoso I; Fernandes R; Guimarães A; Saraiva MJ
Am J Pathol; 2001 Dec; 159(6):1993-2000. PubMed ID: 11733349
[TBL] [Abstract][Full Text] [Related]
12. Clusterin overexpression and its possible protective role in transthyretin deposition in familial amyloidotic polyneuropathy.
Magalhães J; Saraiva MJ
J Neuropathol Exp Neurol; 2011 Dec; 70(12):1097-106. PubMed ID: 22082661
[TBL] [Abstract][Full Text] [Related]
13. Glial cells in familial amyloidotic polyneuropathy.
Gonçalves NP; Costelha S; Saraiva MJ
Acta Neuropathol Commun; 2014 Dec; 2():177. PubMed ID: 25519307
[TBL] [Abstract][Full Text] [Related]
14. Epigallocatechin-3-gallate as a potential therapeutic drug for TTR-related amyloidosis: "in vivo" evidence from FAP mice models.
Ferreira N; Saraiva MJ; Almeida MR
PLoS One; 2012; 7(1):e29933. PubMed ID: 22253829
[TBL] [Abstract][Full Text] [Related]
15. Efficiency of silencing RNA for removal of transthyretin V30M in a TTR leptomeningeal animal model.
Gonçalves P; Martins H; Costelha S; Maia LF; Saraiva MJ
Amyloid; 2016 Dec; 23(4):249-253. PubMed ID: 27884058
[TBL] [Abstract][Full Text] [Related]
16. Up-regulation of the extracellular matrix remodeling genes, biglycan, neutrophil gelatinase-associated lipocalin, and matrix metalloproteinase-9 in familial amyloid polyneuropathy.
Sousa MM; do Amaral JB; Guimarães A; Saraiva MJ
FASEB J; 2005 Jan; 19(1):124-6. PubMed ID: 15536164
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of Protocadherin-10 in Transthyretin-Related Familial Amyloidotic Polyneuropathy.
Gonçalves NP; Martins D; Saraiva MJ
Am J Pathol; 2016 Jul; 186(7):1913-24. PubMed ID: 27338109
[TBL] [Abstract][Full Text] [Related]
18. Sensory nerve degeneration in a mouse model mimicking early manifestations of familial amyloid polyneuropathy due to transthyretin Ala97Ser.
Kan HW; Chiang H; Lin WM; Yu IS; Lin SW; Hsieh ST
Neuropathol Appl Neurobiol; 2018 Dec; 44(7):673-686. PubMed ID: 29423915
[TBL] [Abstract][Full Text] [Related]
19. The transthyretin gene is expressed in Schwann cells of peripheral nerves.
Murakami T; Ohsawa Y; Zhenghua L; Yamamura K; Sunada Y
Brain Res; 2010 Aug; 1348():222-5. PubMed ID: 20547140
[TBL] [Abstract][Full Text] [Related]
20. Transthyretin is not expressed by dorsal root ganglia cells.
Sousa MM; Saraiva MJ
Exp Neurol; 2008 Dec; 214(2):362-5. PubMed ID: 18835560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
